Edition:
United States

People: Eisai Co Ltd (4523.T)

4523.T on Tokyo Stock Exchange

5,969JPY
9:30pm EDT
Change (% chg)

¥-80 (-1.32%)
Prev Close
¥6,049
Open
¥6,002
Day's High
¥6,016
Day's Low
¥5,966
Volume
177,500
Avg. Vol
783,832
52-wk High
¥7,280
52-wk Low
¥5,581

Ohwa, Takashi 

Mr. Takashi Ohwa has been serving as Executive Officer, Chief Medicine Creation Officer of Oncology Business Group and Chief Discovery Officer in Eisai Co., Ltd. since April 2016. He joined the Company in April 1991. He used to be Director of 2nd Drug Development Research Institute and President of Oncology Drug Development Unit in the Company.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --